Piramal Pharma has reported a 22.6% reduction in Scope 1 [...]
Axplora is investing several million euros to expand lyophilisation capacity [...]
Piramal Pharma has reported a 22.6% reduction in Scope 1 [...]
Axplora is investing several million euros to expand lyophilisation capacity [...]